These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31323359)

  • 1. HLA in myasthenia gravis: From superficial correlation to underlying mechanism.
    Zhong H; Zhao C; Luo S
    Autoimmun Rev; 2019 Sep; 18(9):102349. PubMed ID: 31323359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of HLA-DQA1*0101/2 and DQB1*0502 with myasthenia gravis in southern Iranian patients.
    Yousefipour GA; Salami Z; Farjadian S
    Iran J Immunol; 2009 Jun; 6(2):99-102. PubMed ID: 19561379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic basis of myasthenia gravis - a comprehensive review.
    Avidan N; Le Panse R; Berrih-Aknin S; Miller A
    J Autoimmun; 2014 Aug; 52():146-53. PubMed ID: 24361103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics of autoimmune myasthenia gravis: the multifaceted contribution of the HLA complex.
    Vandiedonck C; Giraud M; Garchon HJ
    J Autoimmun; 2005; 25 Suppl():6-11. PubMed ID: 16260117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenetic heterogeneity and associated autoimmune disorders in myasthenia gravis: a population-based survey in the province of Ferrara, northern Italy.
    Tola MR; Caniatti LM; Casetta I; Granieri E; Conighi C; Quatrale R; Monetti VC; Paolino E; Govoni V; Pascarella R
    Acta Neurol Scand; 1994 Nov; 90(5):318-23. PubMed ID: 7887131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA class I and class II polymorphisms in Saudi patients with myasthenia gravis.
    Hajeer AH; Sawidan FA; Bohlega S; Saleh S; Sutton P; Shubaili A; Tahan AA; Al Jumah M
    Int J Immunogenet; 2009 Jun; 36(3):169-72. PubMed ID: 19490212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic heterogeneity within the HLA region in three distinct clinical subgroups of myasthenia gravis.
    Saruhan-Direskeneli G; Hughes T; Yilmaz V; Durmus H; Adler A; Alahgholi-Hajibehzad M; Aysal F; Yentür SP; Akalin MA; Dogan O; Marx A; Gülsen-Parman Y; Oflazer P; Deymeer F; Sawalha AH
    Clin Immunol; 2016 May; 166-167():81-8. PubMed ID: 27181991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of thymic pathology with HLA in myasthenia gravis.
    Machens A; Löliger C; Pichlmeier U; Emskötter T; Busch C; Izbicki JR
    Clin Immunol; 1999 Jun; 91(3):296-301. PubMed ID: 10370374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Leucocyte Antigen B50 Is Associated with Conversion to Generalized Myasthenia Gravis in Patients with Pure Ocular Onset.
    Tiftikcioglu BI; Uludag IF; Zorlu Y; Pirim İ; Sener U; Tokucoglu F; Korucuk M
    Med Princ Pract; 2017; 26(1):71-77. PubMed ID: 27802446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel genetic loci associated HLA-B*08:01 positive myasthenia gravis.
    Varade J; Wang N; Lim CK; Zhang T; Zhang Y; Liu X; Piehl F; Matell R; Cao H; Xu X; Hammarström L
    J Autoimmun; 2018 Mar; 88():43-49. PubMed ID: 29037440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA antigens and myasthenia gravis in north India.
    Mehra NK; Ahuja GK; Taneja V; Vaidya MC
    J Neurol Neurosurg Psychiatry; 1983 Apr; 46(4):361-4. PubMed ID: 6842252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No association of the HLA-DQ alleles with myasthenia gravis in Cuban patients.
    Sylvia T; Samuel M; Luis G; Zuzet M
    Hum Immunol; 2013 Aug; 74(8):983-5. PubMed ID: 23628390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in genetic predisposition of myasthenia gravis.
    Zagoriti Z; Kambouris ME; Patrinos GP; Tzartos SJ; Poulas K
    Biomed Res Int; 2013; 2013():404053. PubMed ID: 24294607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The distribution of HLA-A,B, DR antigens in Chinese myasthenia gravis.
    Thajeb P; Chee CY; Huang CC
    Tissue Antigens; 1987 May; 29(5):273-9. PubMed ID: 3660398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myasthenia gravis, a model of organ-specific autoimmune disease.
    Berrih-Aknin S
    J Autoimmun; 1995 Apr; 8(2):139-43. PubMed ID: 7612144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of HLA-DR/DQ polymorphism with myasthenia gravis in Tunisian patients.
    Fekih-Mrissa N; Klai S; Zaouali J; Gritli N; Mrissa R
    Clin Neurol Neurosurg; 2013 Jan; 115(1):32-6. PubMed ID: 22521184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of sex-related and HLA antigen-bound genetic factors in myasthenia gravis].
    Gyódi KE; Szohor A; Onody K; Klein M; Petrányi GG; Hollán Z
    Orv Hetil; 1980 Mar; 121(13):749-53. PubMed ID: 7383652
    [No Abstract]   [Full Text] [Related]  

  • 18. HLA class II and class I polymorphism in Venezuelan patients with myasthenia gravis.
    Fernández-Mestre MT; Vargas V; Montagnani S; Cotúa M; Ogando V; Layrisse Z
    Hum Immunol; 2004 Jan; 65(1):54-9. PubMed ID: 14700596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible role of HLA-B8 antigen as a genetic marker of autoimmune thrombocytopenia in a patient with myasthenia gravis.
    Remuzzi G; Misiani R; Livio M; dall'Olio A; Donati MB; de Gaetano G
    Thromb Haemost; 1977 Aug; 38(2):593-4. PubMed ID: 413208
    [No Abstract]   [Full Text] [Related]  

  • 20. Thymomatous myasthenia gravis: novel association with HLA DQB1*05:01 and strengthened evidence of high clinical and serological severity.
    Massa R; Greco G; Testi M; Rastelli E; Terracciano C; Frezza E; Garibaldi M; Marfia GA; Locatelli F; Mercuri NB; Pompeo E; Antonini G; Andreani M
    J Neurol; 2019 Apr; 266(4):982-989. PubMed ID: 30741378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.